# Aggressive Treatment of Metabolic Syndrome in Patients Receiving Clozapine for Schizophrenia

> **NCT00794963** · NA · TERMINATED · sponsor: **Northwell Health** · enrollment: 8 (actual)

## Conditions studied

- Metabolic Syndrome

## Interventions

- **DRUG:** Pravastatin, Fenofibrate, Metformin, Orlistat, irbesartan
- **OTHER:** As selected by community physician

## Key facts

- **NCT ID:** NCT00794963
- **Lead sponsor:** Northwell Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-11
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 8 (ACTUAL)
- **Why stopped:** Difficulty recruiting
- **Last updated:** 2015-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00794963

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00794963, "Aggressive Treatment of Metabolic Syndrome in Patients Receiving Clozapine for Schizophrenia". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT00794963. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*